AzTrials
AzTrials

Self- EfficacyNCT05802043

Effect of Cognitive Stimulating Interventions on Cognitive Self-Efficacy and Sense of Happiness Among Older Adults

A study testing Cognitive Stimulating Interventions in people with Self- Efficacy, run by Alexandria University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The present study aims to determine the effect of cognitive stimulation interventions on cognitive self-efficacy and sense of happiness among older adults. Research hypothesis: Older adults who receive the cognitive stimulation interventions exhibit higher cognitive self-efficacy and sense of happiness than those who… Read more about this study

Who is it for?
Ages 60 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Self- Efficacy
What is being tested?
Cognitive Stimulating Interventions
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteEgypt
Study dates
17 Jan 2023to 10 Feb 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

None listed.

Who cannot join

  • 7. Have pronounced impairment of their visual and auditory abilities could affect their participation in the group and make use of most of the materials in the sessions, as determined by the researchers.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculty of Nursing

    Alexandria, 21523

Other trials in Egypt

About this study

Official title: Cognitive Stimulating Interventions Improve Cognitive Self- Efficacy and Sense of Happiness Among Older Adults

The present study aims to determine the effect of cognitive stimulation interventions on cognitive self-efficacy and sense of happiness among older adults.

Research hypothesis:

Older adults who receive the cognitive stimulation interventions exhibit higher cognitive self-efficacy and sense of happiness than those who do not receive it.

Read the detailed description

A convenient sample of eighty (80) older adults will be used according Epi info V 7.0 program calculation based on the following statistical parameters ; Population size: 250, expected frequency: 50%, confidence coefficient: 95%, acceptable error: 10%, minimum sample size = 70.

The study will include eighty (80) older adults aged 60 years and more and fulfilling the following criteria:

Inclusion criteria

  1. Aged 60 years and old.
  2. Able to read and write.
  3. Have mild cognitive impairment: score of score of 18-23 based on the Mini Mental State Examination Scale (MMSE).
  4. Have no depression: score of 0 to 4 using the Geriatric Depression Scale Short Form (GDS_SF).
  5. Accept participation in the study. 6. Available at the selected setting during the time of data collection. 7. Have no pronounced impairment of their visual and auditory abilities could affect their participation in the group and make use of most of the materials in the sessions, as determined by the researchers.

The selected study subjects (80) will be randomly assigned to two equal groups of 40 older adults each as flows; Group 1, study group: include older adults who will receive the proposed interventions, cognitive stimulation interventions.

Group 2, control group: include older adults who will receive the routine activities of the elderly club.

Conditions
Self- Efficacy
Being tested
Cognitive Stimulating Interventions
Keywords
Sense of Happiness, Cognitive Stimulating Interventions

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cognitive Stimulating InterventionsBehavioural

    a quasi-experimental research design.The study subjects of group 1, the study group, will receive the proposed interventions, the cognitive stimulation interventions through small groups of study subjects receiving 12 sessions of group activities (2 sessions/week, approximately 45- 60 minutes/session). A group size of 6 to 8 will be conducted. The interventions group will be conducted in activity rooms within the elderly club.

Study groups in NCT05802043
Study groupRoleWhat they receive
Cognitive Stimulating InterventionsExperimentalThe study interventions will be developed by the researchers based on review of the related literature and with reference to the CST manual (Spector, et al., 2006), and review on Cognitive Stimulation (Woods et al., 2012). The study subjects of group 1, the study group, will receive the proposed interventions, the cognitive stimulation interventions through small groups of study subjects receiving 12 sessions of group activities (2 sessions/week, approximately 45- 60 minutes/session). A group size of 6 to 8 will be conducted. The interventions group will be conducted in activity rooms within the elderl club. The study subjects group 2, the control group, will receive the routine activities of the elderly club. The researchers will provide the control group with written materials related the essential cognitive stimulation interventions after ending the implementation of the proposed interventions for the study group.
Receives: Behavioral: Cognitive Stimulating Interventions
Routine Club careActive comparatorThe study subjects group 2, the control group, will receive the routine activities of the elderly club.The researchers will provide the control group with written materials related the essential cognitive stimulation interventions after ending the implementation of the proposed interventions for the study group,
Receives: Behavioral: Cognitive Stimulating Interventions

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. I) Mini-Mental State Examination (MMS) Scale

    The MMS scale was developed by Folestein et al., (1975). It used to assess cognitive function of the older adults. It contained questions concerning registration, orientation, calculation, recall, attention, and language. The MMS scale score was 30 point and classified as follows: -30. -23. -17.

    The MMS was translated into Arabic and approved to be valid and reliable (r=0.96) by El Husseini (2008). The Arabic version of this scale was used in the present study.

    Measured: 2 weeks

Secondary outcomes (1)
  1. II) Geriatric Depression Scale- Short Form (GDS-SF)

    The Geriatric Depression Scale - short Form (GDS-SF), a self-report tool with 15-item developed by Yesavage et al. (1983) to assess general well-being and depression in the elderly. The older adults should select one answer either yes (1) or no (0) for their feelings over the past week. The scores ranged from 0 to 15. Items' score will be calculated for the total score. A score of 0 to 4 meant no depression, score of 5 to 8 meant mild depression, score of 9 to 11 meant moderate depression, and 12-15 meant severe depression.

    The GDS-SF was translated into Arabic and approved to be reliable (r=0.70) and valid by ElHusseini (2013). The Arabic version of this scale was used in the current study.

    Measured: 2 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Apr 2023
  2. Study start17 Jan 2023
  3. Primary completion1 Feb 2023
  4. Study completion10 Feb 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
80 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05802043
Sponsor's protocol ID
15012023
Status last verified
Jan 2023
First submitted
25 Mar 2023
Last updated
6 Apr 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Apostolo J, Bobrowicz-Campos E, Holland C, Cano A. One small step in frailty research, a giant leap in evidence based practice. JBI Database System Rev Implement Rep. 2018 Jan;16(1):1-3. doi: 10.11124/JBISRIR-2017-003672. No abstract available.

    PubMed 29324548
  • Coen RF, Flynn B, Rigney E, O'Connor E, Fitzgerald L, Murray C, Dunleavy C, McDonald M, Delaney D, Merriman N, Edgeworth J. Efficacy of a cognitive stimulation therapy programme for people with dementia. Ir J Psychol Med. 2011 Sep;28(3):145-147. doi: 10.1017/S0790966700012131.

    PubMed 30200025
  • Feng L, Zin Nyunt MS, Gao Q, Feng L, Yap KB, Ng TP. Cognitive Frailty and Adverse Health Outcomes: Findings From the Singapore Longitudinal Ageing Studies (SLAS). J Am Med Dir Assoc. 2017 Mar 1;18(3):252-258. doi: 10.1016/j.jamda.2016.09.015. Epub 2016 Nov 9.

    PubMed 27838339
  • Kelly ME, Finan S, Lawless M, Scully N, Fitzpatrick J, Quigley M, Tyrrell F, O'Regan A, Devane A. An evaluation of community-based cognitive stimulation therapy: a pilot study with an Irish population of people with dementia. Ir J Psychol Med. 2017 Sep;34(3):157-167. doi: 10.1017/ipm.2016.23.

    PubMed 30115146

Questions about this trial

What is this clinical trial studying?

A study testing Cognitive Stimulating Interventions in people with Self- Efficacy, run by Alexandria University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 0 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Apr 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

I) Mini-Mental State Examination (MMS) Scale (time frame: 2 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05802043, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Apr 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in